Literature DB >> 20304552

Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium.

Bob Djavan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20304552     DOI： 10.1016/j.eururo.2010.03.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.

Authors:  Thomas Rhodes; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; Cynthia J Girman; Michael M Lieber; George G Klee; Kitaw Demissie; Steven J Jacobsen
Journal:  Urology       Date:  2012-03       Impact factor: 2.649

Review 2.  Toward the detection of prostate cancer in urine: a critical analysis.

Authors:  Matthew Truong; Bing Yang; David F Jarrard
Journal:  J Urol       Date:  2012-09-24       Impact factor: 7.600

3.  Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program.

Authors:  Isabel Heidegger; Josef Fritz; Helmut Klocker; Renate Pichler; Jasmin Bektic; Wolfgang Horninger
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

Review 4.  PSA mass screening: is there enough evidence?

Authors:  Bernardo Rocco; Angelica Grasso; Roman Sosnowski; Paolo Guido Dell'orto; Giancarlo Albo; Erik Castle; Rafael Coelho; Vip Patel; Alex Mottrie
Journal:  Cent European J Urol       Date:  2012-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.